NASDAQ:SDGR Schrödinger (SDGR) Stock Price, News & Analysis $22.42 +0.13 (+0.58%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$22.06▼$22.9650-Day Range$18.65▼$24.0252-Week Range$18.21▼$52.81Volume440,274 shsAverage Volume795,124 shsMarket Capitalization$1.63 billionP/E RatioN/ADividend YieldN/APrice Target$38.90 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Get Schrödinger alerts: Email Address Schrödinger MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.82 Rating ScoreUpside/Downside73.5% Upside$38.90 Price TargetShort InterestBearish11.28% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.33Based on 9 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($2.83) to ($1.54) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.47 out of 5 starsMedical Sector533rd out of 936 stocksPharmaceutical Preparations Industry241st out of 436 stocks 4.4 Analyst's Opinion Consensus RatingSchrödinger has received a consensus rating of Moderate Buy. The company's average rating score is 2.82, and is based on 7 buy ratings, 3 hold ratings, and no sell ratings.Amount of Analyst CoverageSchrödinger has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Schrödinger's stock forecast and price target. Previous Next 1.0 Short Interest Percentage of Shares Shorted11.28% of the outstanding shares of Schrödinger have been sold short.Short Interest Ratio / Days to CoverSchrödinger has a short interest ratio ("days to cover") of 11.3, which indicates bearish sentiment.Change versus previous monthShort interest in Schrödinger has recently decreased by 0.85%, indicating that investor sentiment is improving. Previous Next 0.0 Dividend Strength Dividend YieldSchrödinger does not currently pay a dividend.Dividend GrowthSchrödinger does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for SDGR. Previous Next 1.8 News and Social Media Coverage News SentimentSchrödinger has a news sentiment score of 0.33. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.62 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 9 news articles for Schrödinger this week, compared to 3 articles on an average week.Search InterestOnly 7 people have searched for SDGR on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added Schrödinger to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Schrödinger insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 8.60% of the stock of Schrödinger is held by insiders.Percentage Held by Institutions79.05% of the stock of Schrödinger is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Schrödinger's insider trading history. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Schrödinger are expected to grow in the coming year, from ($2.83) to ($1.54) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Schrödinger is -11.93, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Schrödinger is -11.93, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioSchrödinger has a P/B Ratio of 2.95. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Schrödinger's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad WealthPressNew trading system called MSFT, NVDA & MSFTLook 2023 kind of sucked from a trading standpoint… Despite the market finishing 24% higher…. Just seven stocks did all of the work… Unless you were holding or actively trading those 7 stocks, your trading year probably wasn’t as fruitful as you had hoped… According to my research, my new trading system would have spotted all seven of the “Magnificent stocks” MONTHS before they reached the highs they are trading at today.Just follow this link here! About Schrödinger Stock (NASDAQ:SDGR)Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.Read More SDGR Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SDGR Stock News HeadlinesJuly 5, 2024 | marketbeat.comSimulations Plus Stock Drops 15% Despite EPS Beat (SDGR)Simulations Plus fell 15% the day after its earnings release despite beating EPS estimates due to lower margins and lower full-year guidance.July 26 at 7:39 AM | stockhouse.comSchrödinger Launches Initiative to Significantly Expand Application of Computational Tools for Predictive ToxicologyJuly 26, 2024 | American Hartford Gold Group (Ad)Prepare for a Recession Unlike Any OtherDave Ramsey Is Dangerously Wrong And Here’s Why>> Asked whether we’re on the cusp of a US Dollar crash, Dave Ramsey made a stunning miscalculation while live on air: “Am I worried about this? Absolutely not.” Frankly, I've never seen someone so confident in being wrong… Because what’s happening to the US Dollar is not something you should “keep an eye on”… But instead, is an imminent threat you should get ahead of right NOW.July 24 at 10:17 AM | americanbankingnews.comFinancial Review: Immunome (NASDAQ:IMNM) versus Schrödinger (NASDAQ:SDGR)July 23 at 7:46 PM | finance.yahoo.comWe're Not Very Worried About Schrödinger's (NASDAQ:SDGR) Cash Burn RateJuly 23 at 2:02 AM | americanbankingnews.comSchrödinger, Inc. (NASDAQ:SDGR) Receives $38.90 Consensus Target Price from BrokeragesJuly 22, 2024 | investorplace.com3 Stocks That Could Benefit Big Time From Coming Interest Rate CutsJuly 19, 2024 | finance.yahoo.comSchrödinger to Announce Second Quarter 2024 Financial Results on July 31July 26, 2024 | WealthPress (Ad)This TSLA short trade is on a nine win hot streakMost Tesla Shareholders are disappointed in the stock's performance in 2024. Year to date, it's down 30%... And things don’t seem to be getting better. That said, one professional trader has found a way to turn Tesla’s demise into a flurry of opportunity… In fact, he has not lost a single trade on Tesla this year. As of this mailing he’s 9 for 9 with incredible wins under his belt. Just see for yourself.July 3, 2024 | investorplace.com3 Top-Rated Gene Editing Stocks Actually Making MoneyJune 14, 2024 | businesswire.comSchrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)June 4, 2024 | seekingalpha.comSchrodinger: Buy The Drug-Discovery Platform And Get The Pipeline Nearly For FreeJune 1, 2024 | 247wallst.com1 Growth Stock That Could Dominate AI's Next BreakthroughMay 22, 2024 | msn.com3 Small-Cap Stocks to Invest in AI Drug DevelopmentMay 22, 2024 | businesswire.comSchrödinger to Present at Jefferies Global Healthcare ConferenceMay 17, 2024 | businesswire.comSchrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)May 16, 2024 | morningstar.comSchrodinger Inc Ordinary SharesMay 16, 2024 | investorplace.com7 Pharma Stocks Harnessing AI Brainpower for Big BreakthroughsSee More Headlines Receive SDGR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Schrödinger and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/01/2024Today7/26/2024Next Earnings (Confirmed)7/31/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolNASDAQ:SDGR CUSIPN/A CIK1490978 Webwww.schrodinger.com Phone212-295-5800FaxN/AEmployees867Year FoundedN/APrice Target and Rating Average Stock Price Target$38.90 High Stock Price Target$67.00 Low Stock Price Target$25.00 Potential Upside/Downside+73.5%Consensus RatingModerate Buy Rating Score (0-4)2.82 Research Coverage11 Analysts Profitability EPS (Most Recent Fiscal Year)($1.88) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$40.72 million Net Margins-75.94% Pretax Margin-88.52% Return on Equity-29.25% Return on Assets-20.60% Debt Debt-to-Equity RatioN/A Current Ratio4.64 Quick Ratio4.64 Sales & Book Value Annual Sales$216.67 million Price / Sales7.52 Cash Flow$0.66 per share Price / Cash Flow34.05 Book Value$7.60 per share Price / Book2.95Miscellaneous Outstanding Shares72,680,000Free Float66,429,000Market Cap$1.63 billion OptionableOptionable Beta1.51 7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free Report Key ExecutivesDr. Ramy Farid Ph.D. (Age 59)CEO, President & Director Comp: $1.06MDr. Richard A. Friesner Ph.D. (Age 71)Co-Founder, Scientific Advisory Chairman and Director Comp: $465kDr. Geoffrey Craig Porges MBBSExecutive VP & CFODr. Robert Lorne Abel Ph.D. (Age 42)Executive VP, Chief Scientific Officer of Platform and Head of Modeling R&D Comp: $569.45kDr. Karen Akinsanya Ph.D. (Age 56)President of Research & Development Therapeutics Comp: $797.74kDr. Margaret Han Dugan M.D. (Age 67)Chief Medical Officer Comp: $707.46kProf. William Goddard IIICo-Founder & Scientific AdvisorMr. Kenneth Patrick Lorton (Age 40)Executive VP, CTO & COO of Software Comp: $510.09kMr. Shane Brauner (Age 46)Executive VP & Chief Information Officer Ms. Jaren Irene MaddenSenior Vice President of Investor Relations & Corporate CommunicationsMore ExecutivesKey CompetitorsSage TherapeuticsNASDAQ:SAGEEmergent BioSolutionsNYSE:EBSAllakosNASDAQ:ALLKTurning Point TherapeuticsNASDAQ:TPTXForty SevenNASDAQ:FTSVView All CompetitorsInsiders & InstitutionsARK Investment Management LLCSold 70,356 shares on 7/26/2024Ownership: 3.368%Bank of New York Mellon CorpBought 35,036 shares on 7/26/2024Ownership: 0.689%Allspring Global Investments Holdings LLCSold 8,967 shares on 7/26/2024Ownership: 0.215%Baillie Gifford & Co.Sold 487,039 shares on 7/25/2024Ownership: 2.924%Louisiana State Employees Retirement SystemBought 700 shares on 7/24/2024Ownership: 0.038%View All Insider TransactionsView All Institutional Transactions SDGR Stock Analysis - Frequently Asked Questions How have SDGR shares performed this year? Schrödinger's stock was trading at $35.80 on January 1st, 2024. Since then, SDGR stock has decreased by 37.4% and is now trading at $22.42. View the best growth stocks for 2024 here. How were Schrödinger's earnings last quarter? Schrödinger, Inc. (NASDAQ:SDGR) announced its earnings results on Wednesday, May, 1st. The company reported ($0.76) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.76). The business earned $36.60 million during the quarter, compared to the consensus estimate of $41.23 million. Schrödinger had a negative trailing twelve-month return on equity of 29.25% and a negative net margin of 75.94%. What is Ramy Farid's approval rating as Schrödinger's CEO? 8 employees have rated Schrödinger Chief Executive Officer Ramy Farid on Glassdoor.com. Ramy Farid has an approval rating of 95% among the company's employees. This puts Ramy Farid in the top 30% of approval ratings compared to other CEOs of publicly-traded companies. When did Schrödinger IPO? Schrödinger (SDGR) raised $150 million in an IPO on Thursday, February 6th 2020. The company issued 10,000,000 shares at a price of $14.00-$16.00 per share. Morgan Stanley, BofA Securities, Jefferies and BMO Capital Markets served as the underwriters for the IPO. Who are Schrödinger's major shareholders? Schrödinger's top institutional investors include ARK Investment Management LLC (3.37%), Sumitomo Mitsui Trust Holdings Inc. (2.97%), Baillie Gifford & Co. (2.92%) and Bank of New York Mellon Corp (0.69%). Insiders that own company stock include Ramy Farid, Kenneth Patrick Lorton, Yvonne Tran, Jenny Herman, Robert Lorne Abel, Nancy Thornberry and Karen Akinsanya. View institutional ownership trends. How do I buy shares of Schrödinger? Shares of SDGR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Schrödinger own? Based on aggregate information from My MarketBeat watchlists, some other companies that Schrödinger investors own include NVIDIA (NVDA), Marvell Technology (MRVL), Tesla (TSLA), Advanced Micro Devices (AMD), Alibaba Group (BABA), Block (SQ) and Cisco Systems (CSCO). This page (NASDAQ:SDGR) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Schrödinger, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Schrödinger With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
